Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Corindus Vascular Robotics Inc stock logo
CVRS
Corindus Vascular Robotics
$4.27
$4.27
$0.78
$4.40
$891.09MN/A1.99 million shsN/A
LivaNova PLC stock logo
LIVN
LivaNova
$41.88
-3.0%
$38.77
$32.48
$61.94
$2.35B0.84650,163 shs602,740 shs
Envista Holdings Co. stock logo
NVST
Envista
$16.73
-0.8%
$16.57
$14.22
$23.00
$2.83B0.972.56 million shs2.06 million shs
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
$57.38
-0.6%
$55.28
$47.04
$103.81
$3.17B1.1818,018 shs557,872 shs
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Corindus Vascular Robotics Inc stock logo
CVRS
Corindus Vascular Robotics
0.00%0.00%0.00%0.00%0.00%
LivaNova PLC stock logo
LIVN
LivaNova
-3.01%-5.68%+15.28%-11.72%-30.86%
Envista Holdings Co. stock logo
NVST
Envista
-0.63%-8.27%+6.25%-19.95%-10.20%
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
-0.59%-1.19%+3.02%-7.82%-14.43%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Corindus Vascular Robotics Inc stock logo
CVRS
Corindus Vascular Robotics
N/AN/AN/AN/AN/AN/AN/AN/A
LivaNova PLC stock logo
LIVN
LivaNova
3.7815 of 5 stars
4.53.00.00.03.51.71.3
Envista Holdings Co. stock logo
NVST
Envista
4.1753 of 5 stars
3.13.00.03.82.90.02.5
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
2.785 of 5 stars
3.42.00.00.03.13.30.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Corindus Vascular Robotics Inc stock logo
CVRS
Corindus Vascular Robotics
0.00
N/AN/AN/A
LivaNova PLC stock logo
LIVN
LivaNova
3.00
Buy$59.2941.56% Upside
Envista Holdings Co. stock logo
NVST
Envista
2.14
Hold$20.0819.98% Upside
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
2.86
Moderate Buy$90.0056.85% Upside

Current Analyst Ratings Breakdown

Latest CVRS, PRCT, NVST, and LIVN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/20/2025
LivaNova PLC stock logo
LIVN
LivaNova
Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradePeer Perform ➝ Outperform$60.00
5/13/2025
LivaNova PLC stock logo
LIVN
LivaNova
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$64.00 ➝ $64.00
5/8/2025
LivaNova PLC stock logo
LIVN
LivaNova
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$56.00 ➝ $55.00
5/8/2025
LivaNova PLC stock logo
LIVN
LivaNova
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$55.00 ➝ $61.00
5/5/2025
Envista Holdings Co. stock logo
NVST
Envista
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$21.00 ➝ $18.00
5/2/2025
Envista Holdings Co. stock logo
NVST
Envista
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$21.00
4/30/2025
Envista Holdings Co. stock logo
NVST
Envista
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$18.00 ➝ $17.00
4/29/2025
Envista Holdings Co. stock logo
NVST
Envista
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$26.00 ➝ $23.00
4/25/2025
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$104.00 ➝ $84.00
4/15/2025
Envista Holdings Co. stock logo
NVST
Envista
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$16.00
4/11/2025
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$90.00 ➝ $70.00
(Data available from 5/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Corindus Vascular Robotics Inc stock logo
CVRS
Corindus Vascular Robotics
N/AN/AN/AN/AN/AN/A
LivaNova PLC stock logo
LIVN
LivaNova
$1.28B1.79$3.76 per share11.15$23.72 per share1.77
Envista Holdings Co. stock logo
NVST
Envista
$2.50B1.13$1.30 per share12.91$17.04 per share0.98
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
$249.12M12.74N/AN/A$5.56 per share10.32
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Corindus Vascular Robotics Inc stock logo
CVRS
Corindus Vascular Robotics
N/AN/A0.00N/AN/AN/AN/AN/A
LivaNova PLC stock logo
LIVN
LivaNova
$17.55M-$4.0999.7113.34N/A1.91%13.81%7.07%7/30/2025 (Estimated)
Envista Holdings Co. stock logo
NVST
Envista
-$1.12B-$6.53N/A13.831.27-44.56%3.86%2.21%8/6/2025 (Estimated)
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
-$105.90M-$1.70N/AN/AN/A-50.07%-38.57%-26.06%8/7/2025 (Estimated)

Latest CVRS, PRCT, NVST, and LIVN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/1/2025Q1 2025
Envista Holdings Co. stock logo
NVST
Envista
$0.20$0.24+$0.04$0.10$608.17 million$616.90 million
4/24/2025Q1 2025
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
-$0.49-$0.45+$0.04-$0.45$65.39 million$69.16 million
2/25/2025Q4 2024
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
-$0.34-$0.35-$0.01-$0.35$66.79 million$68.24 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Corindus Vascular Robotics Inc stock logo
CVRS
Corindus Vascular Robotics
N/AN/AN/AN/AN/A
LivaNova PLC stock logo
LIVN
LivaNova
N/AN/AN/AN/AN/A
Envista Holdings Co. stock logo
NVST
Envista
N/AN/AN/AN/AN/A
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Corindus Vascular Robotics Inc stock logo
CVRS
Corindus Vascular Robotics
N/AN/AN/A
LivaNova PLC stock logo
LIVN
LivaNova
0.46
3.37
2.87
Envista Holdings Co. stock logo
NVST
Envista
0.44
2.04
1.76
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
0.21
6.02
5.07

Institutional Ownership

CompanyInstitutional Ownership
Corindus Vascular Robotics Inc stock logo
CVRS
Corindus Vascular Robotics
N/A
LivaNova PLC stock logo
LIVN
LivaNova
97.64%
Envista Holdings Co. stock logo
NVST
Envista
N/A
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
89.46%

Insider Ownership

CompanyInsider Ownership
Corindus Vascular Robotics Inc stock logo
CVRS
Corindus Vascular Robotics
N/A
LivaNova PLC stock logo
LIVN
LivaNova
0.29%
Envista Holdings Co. stock logo
NVST
Envista
1.30%
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
17.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
Corindus Vascular Robotics Inc stock logo
CVRS
Corindus Vascular Robotics
90208.69 millionN/ANot Optionable
LivaNova PLC stock logo
LIVN
LivaNova
2,90054.53 million54.15 millionOptionable
Envista Holdings Co. stock logo
NVST
Envista
12,700169.49 million169.95 millionOptionable
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
43055.33 million43.10 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Corindus Vascular Robotics stock logo

Corindus Vascular Robotics NYSEAMERICAN:CVRS

$4.27 0.00 (0.00%)
As of 11/27/2019

Corindus Vascular Robotics, Inc. designs, manufactures, and sells robotic-assisted systems for use in interventional vascular procedures in the United States and internationally. The company offers CorPath system, a medical device with robotic-assisted precision for coronary and peripheral interventional procedures. Its CorPath system allows the physician to perform procedures with a control console located within an interventional cockpit; and CorPath GRX system enables the precise robotic-assisted control of guide catheters, guidewires, and balloon/stent devices from the safety of a radiation-shielded interventional cockpit. The company sells its products through direct sales force, as well as through distributor and partnership relationships. It serves vascular, coronary, peripheral vascular, neurointerventional, and structural heart markets. Corindus Vascular Robotics, Inc. is headquartered in Waltham, Massachusetts.

LivaNova stock logo

LivaNova NASDAQ:LIVN

$41.88 -1.30 (-3.01%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$43.46 +1.58 (+3.78%)
As of 05/23/2025 04:26 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.

Envista stock logo

Envista NYSE:NVST

$16.73 -0.14 (-0.81%)
Closing price 05/23/2025 03:59 PM Eastern
Extended Trading
$16.72 -0.02 (-0.11%)
As of 05/23/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

PROCEPT BioRobotics stock logo

PROCEPT BioRobotics NASDAQ:PRCT

$57.38 -0.34 (-0.59%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$58.02 +0.64 (+1.12%)
As of 05/23/2025 07:19 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.